2. Â Â Â Â Leach A. molecular modelling: principles and applications-prentice hall. Second. England: Pearson Education Limited; 2001. 1--773 p.
3. Â Â Â Â Jensen F. introduction to computational chemistry computational chemistry. third edit. UK: John Wiley & Sons; 2017. 1--638 p.
4. Â Â Â Â Nugraha G, Istyastono EP. Pembuatan protokol penapisan virtual berbasis stuktur (PVBS) untuk identifikasi ligan inhibitor reseptor platelet-activating factor (PAF-r) sebagai target terapeutik ssma menggunakan YASARA. J Ris Kim. 2020;11(1):35--42.
5. Â Â Â Â Vilar S, Cozza G, Moro S. medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8(18):1--18.
6. Â Â Â Â Tan L, Geppert H, Sisay MT, Gtschow M, Bajorath J. integrating structure- and ligand-based virtual screening: Comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets. ChemMedChem. 2008;3(10):1--6.
7. Â Â Â Â Cavasotto CN, Orry AJW. ligand docking and virtual screening in structure-based drug discovery. Curr Top Med Chem. 2007;7:1006--14.
8. Â Â Â Â Verdonk ML, Berdini V, Hartshorn MJ, Mooij WTM, Murray CW, Taylor RD, et al. virtual screening using protein-ligand docking: Avoiding artificial enrichment. J Chem Inf Comput Sci. 2004;44(3):1--14.
9. Â Â Â Â Marcou G, Rognan D. optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J Chem Inf Model. 2007;47(1):1--13.
10. Â Â Â Hou T, Xu X. Recent Development and Application of Virtual Screening in Drug Discovery: An Overview. Front Med Chem - (Volume 3). 2012;675--703.
11. Â Â Â Cheng T, Li Q, Zhou Z, Wang Y, Bryant SH. structure-based virtual screening for drug discovery: A problem-centric review. AAPS J. 2012;14(1):1--9.
12. Â Â Â Leach AR, Shoichet BK, Peishoff CE. docking and scoring. Am Chem Soc. 2006;49(20):1--5.